![Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database | Annals of the Rheumatic Diseases Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/66/6/754/F2.large.jpg)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database | Annals of the Rheumatic Diseases
![Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. - Abstract - Europe PMC Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. - Abstract - Europe PMC](https://europepmc.org/articles/PMC1954657/bin/ar62901.f1.jpg)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. - Abstract - Europe PMC
![Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database | The Journal of Rheumatology Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/37/7/1488/F2.large.jpg)